Given the complex interactions between CCN5, ER, and progression of BC, the aim of the current study was to analyse the expression of CCN5 and ER in normal breast tissue, ductal carcinoma in situ (DCIS), and invasive carcinoma tissues of patients with advanced BC. Here, CCN5 is linked to ductal breast carcinoma in situ.